Ultima Genomics is unleashing the power of genomics at scale. Ultima's revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information. The new sequencing architecture was designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information and catalyze the next phase of genomics in the 21st century.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/02/22 | $600,000,000 |
aMoon Andreessen Horowitz D1 Capital Partners Founders Fund General Atlantic Playground Global | undisclosed |
